Validation of VI-RADS for the Detection of Detrusor Muscle Invasion
Multiparametric MRI for Bladder Cancer: Validation of VI-RADS for the Detection of Detrusor Muscle Invasion
1 other identifier
interventional
60
1 country
1
Brief Summary
To evaluate the accuracy of Multiparametric MRI in differentiation between invasive and non-invasive bladder cancer using vesical imaging reporting and data system (VI-RADS) score.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 4, 2021
CompletedFirst Submitted
Initial submission to the registry
November 5, 2021
CompletedFirst Posted
Study publicly available on registry
November 17, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2022
CompletedNovember 17, 2021
November 1, 2021
2 months
November 5, 2021
November 5, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
sensitivity and specificity of ViRADS SCORE
4 months
Study Arms (1)
intervention arm
EXPERIMENTALPatients will undergo MRI followed by TURBT
Interventions
In our study we aim to evaluate role of Multiparametric MRI in differentiation between invasive and non-invasive bladder cancer and accuracy of vesical imaging reporting and data system (VI-RADS) score.
detection of degree of invasion to test accuracy of ViRADS score
Eligibility Criteria
You may qualify if:
- Patients with bladder mass diagnosed by U/S ,CT or MRI and scheduled for cystoscopy
You may not qualify if:
- Patients with general contraindication for MRI examination (as metallic prosthesis, pacemaker or claustrophobia).
- Patients with contraindication for transurethral resection (TUR) (as those unfit for anesthesia).
- Patients with high renal functions, as they are contraindicated for dynamic contrast enhancing imaging.
- Patients there histopathology proved that their bladder mass not TCC.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Egyptian Biomedical Research Networklead
- Ain Shams Universitycollaborator
Study Sites (1)
Ain Shams University
Cairo, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- NETWORK
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Urology
Study Record Dates
First Submitted
November 5, 2021
First Posted
November 17, 2021
Study Start
November 4, 2021
Primary Completion
January 1, 2022
Study Completion
March 1, 2022
Last Updated
November 17, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will not share